Actavis Implements Eluzzion CRM in Slovakia

Data3s, a global provider of pharma-focused CRM software, today announced that Actavis Slovakia has successfully implemented eluzzion CRM, Data3s' flagship product for life science companies, to support their country sales organization.

Prague (I-Newswire) October 11, 2011 - Data3s, a global provider of pharma-focused customer relationship management (CRM) and business intelligence (BI) software, today announced that Actavis Slovakia has successfully implemented eluzzion CRM, Data3s' flagship product for life science companies, to support their country sales organization.

Milan Cernek, the Country Manager of Actavis Slovakia, impressed by the incredible speed of implementation, announced that is was "probably the fastest implementation of CRM in history."

The decision to implement eluzzion CRM in Slovakia adds a third country to a roster that already includes Actavis Spain and Actavis Italy, who this year selected eluzzion CRM to support their own sales forces.

According to Data3s CEO Antonín Lukeš, Actavis Slovakia's decision to replace their legacy solution with eluzzion CRM was due in part of the extensive reporting capability offered by the software, as well as its "clear value for money" when compared with other available solutions.

"eluzzion CRM offers not only advanced reporting and data analysis," said Mr. Lukeš, "but a breadth of functionality that goes far beyond what the current crop of CRM systems offers. With eluzzion CRM, Actavis Slovakia will benefit from a truly organization-wide collaboration tool that will enable all departments, from finance through HR, to support the sales organization."

According to Cristian Burrows, Data3s' Sales Director, the deal in Slovakia brings even more benefits to Actavis as a group since information can now be more easily compared amongst countries.

"The real value of eluzzion from a corporate standpoint," said Mr. Burrows, "is its ability to support top-level management as a collaboration tool between countries, not just within them. We have a whole host of very well structured cross-country reports that will give European management a much clearer picture of what's happening in different countries, with the ability to drill down and compare an incredible wealth of detail."

About Actavis

The Actavis Group is one of the world’s leading players in the development, manufacture and sale of high-quality generic pharmaceuticals. The successful integration of a number of acquisitions has helped position Actavis among the world’s largest companies in the industry. Founded in 1956, the Group has more than 10,000 employees operating in about 40 countries around the globe.